Table 2 Studies on OCTA parameters in patients with AD, MCI and preclinical AD
From: Advances in retina imaging as potential biomarkers for early diagnosis of Alzheimer’s disease
Authors | Year of publication | Parameters | Subjects | Alteration |
|---|---|---|---|---|
Bulut M et al. [71] | 2018 | SRCP-VD, DRCP-VD, FAZ | AD | Lower VD, enlarged FAZ. |
Lahme L et al. [72] | 2018 | SRCP-flow density, DRCP-flow density, Peripapillary-VD | AD | Lower SRCP-flow density |
Jiang et al. [73] | 2017 | SRCP-VD, DRCP-VD | AD MCI | AD had lower VD of SRCP and DRCP. MCI had lower VD of DRCP in the superior nasal quadrant |
Stephen P et al. [74] | 2019 | SRCP-VD, FAZ | AD MCI | AD had lower SRCP-VD. No difference in MCI |
Zhang et al. [75] | 2019 | SRCP-VD, DRCP-VD, RPC | MCI or early AD | Lower SRCP-VD |
Wu et al. [76] | 2020 | SRCP-VD, DRCP-VD, FAZ | AD MCI | Lower DRCP-VD |
O’Bryhim et al. [77] | 2018 | SRCP-VD, FAZ | Preclinical AD | Lower VD, enlarged FAZ |
van de Kreeke et al. [78] | 2020 | Macular-VD, Peripapillary-VD, FAZ | Preclinical AD | Higher VD, no difference in FAZ. |